DAPA-RESIST clinical trial - Dapagliflozin versus metolazone in heart failure with diuretic resistance
21 May 2023 (11:51 - 12:03)
Organised by: 
Slides
About the speaker
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
4 More presentations in this session
Doctor M. Vaduganathan (Boston, US)
Doctor M. Kosiborod (Kansas City, US)
Professor A. Voors (Groningen, NL)
Access the full session
The Event
Heart Failure 2023
21 May 2023
11:51 CET
You may be interested in
Congress Session
Congress Presentation
